| Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid S Kataoka, K Takuma, Y Hara, Y Maeda, Y Ago, T Matsuda International journal of Neuropsychopharmacology 16 (1), 91-103, 2013 | 339 | 2013 |
| Chronic treatment with valproic acid or sodium butyrate attenuates novel object recognition deficits and hippocampal dendritic spine loss in a mouse model of autism K Takuma, Y Hara, S Kataoka, T Kawanai, Y Maeda, R Watanabe, ... Pharmacology biochemistry and behavior 126, 43-49, 2014 | 133 | 2014 |
| Environmental enrichment attenuates behavioral abnormalities in valproic acid-exposed autism model mice H Yamaguchi, Y Hara, Y Ago, E Takano, S Hasebe, T Nakazawa, ... Behavioural brain research 333, 67-73, 2017 | 92 | 2017 |
| Effect of prenatal valproic acid exposure on cortical morphology in female mice Y Hara, Y Maeda, S Kataoka, Y Ago, K Takuma, T Matsuda Journal of pharmacological sciences 118 (4), 543-546, 2012 | 73 | 2012 |
| Oxytocin attenuates deficits in social interaction but not recognition memory in a prenatal valproic acid-induced mouse model of autism Y Hara, Y Ago, M Higuchi, S Hasebe, T Nakazawa, H Hashimoto, ... Hormones and behavior 96, 130-136, 2017 | 65 | 2017 |
| Improvement by methylphenidate and atomoxetine of social interaction deficits and recognition memory impairment in a mouse model of valproic acid‐induced autism Y Hara, Y Ago, A Taruta, K Katashiba, S Hasebe, E Takano, Y Onaka, ... Autism Research 9 (9), 926-939, 2016 | 61 | 2016 |
| Risperidone and aripiprazole alleviate prenatal valproic acid-induced abnormalities in behaviors and dendritic spine density in mice Y Hara, Y Ago, A Taruta, S Hasebe, H Kawase, W Tanabe, S Tsukada, ... Psychopharmacology 234, 3217-3228, 2017 | 55 | 2017 |
| Reduced prefrontal dopaminergic activity in valproic acid-treated mouse autism model Y Hara, K Takuma, E Takano, K Katashiba, A Taruta, K Higashino, ... Behavioural brain research 289, 39-47, 2015 | 55 | 2015 |
| A highly active form of XCL1/lymphotactin functions as an effective adjuvant to recruit cross-presenting dendritic cells for induction of effector and memory CD8+ T cells K Matsuo, K Kitahata, F Kawabata, M Kamei, Y Hara, S Takamura, N Oiso, ... Frontiers in immunology 9, 2775, 2018 | 47 | 2018 |
| Prenatal exposure to valproic acid increases miR-132 levels in the mouse embryonic brain Y Hara, Y Ago, E Takano, S Hasebe, T Nakazawa, H Hashimoto, ... Molecular autism 8, 1-9, 2017 | 39 | 2017 |
| A CCR4 antagonist ameliorates atopic dermatitis-like skin lesions induced by dibutyl phthalate and a hydrogel patch containing ovalbumin K Matsuo, S Hatanaka, Y Kimura, Y Hara, K Nishiwaki, YS Quan, ... Biomedicine & Pharmacotherapy 109, 1437-1444, 2019 | 32 | 2019 |
| Recent progress in dendritic cell-based cancer immunotherapy K Matsuo, O Yoshie, K Kitahata, M Kamei, Y Hara, T Nakayama Cancers 13 (10), 2495, 2021 | 31 | 2021 |
| Anti‐tumor effects of an antagonistic mAb against the ASCT2 amino acid transporter on KRAS‐mutated human colorectal cancer cells Y Hara, Y Minami, S Yoshimoto, N Hayashi, A Yamasaki, S Ueda, ... Cancer Medicine 9 (1), 302-312, 2020 | 25 | 2020 |
| Anti‐tumor effects of mAb against l‐type amino acid transporter 1 (LAT1) bound to human and monkey LAT1 with dual avidity modes S Ueda, H Hayashi, T Miyamoto, S Abe, K Hirai, K Matsukura, H Yagi, ... Cancer science 110 (2), 674-685, 2019 | 25 | 2019 |
| Inhibition of tumor formation and metastasis by a monoclonal antibody against lymphatic vessel endothelial hyaluronan receptor 1 Y Hara, R Torii, S Ueda, E Kurimoto, E Ueda, H Okura, Y Tatano, H Yagi, ... Cancer Science 109 (10), 3171-3182, 2018 | 25 | 2018 |
| Antitumor effects of novel mAbs against cationic amino acid transporter 1 (CAT1) on human CRC with amplified CAT1 gene K Okita, Y Hara, H Okura, H Hayashi, Y Sasaki, S Masuko, E Kitadai, ... Cancer Science 112 (2), 563-574, 2021 | 16 | 2021 |
| Ascorbic acid derivative DDH-1 ameliorates psoriasis-like skin lesions in mice by suppressing inflammatory cytokine expression K Kitahata, K Matsuo, Y Hara, T Naganuma, N Oiso, A Kawada, ... Journal of Pharmacological Sciences 138 (4), 284-288, 2018 | 15 | 2018 |
| CCR4 involvement in the expansion of T helper type 17 cells in a mouse model of psoriasis K Matsuo, K Kitahata, Y Kaibori, Y Arima, A Iwama, M Ito, Y Hara, ... Journal of Investigative Dermatology 141 (8), 1985-1994, 2021 | 14 | 2021 |
| mS-11, a mimetic of the mSin3-binding helix in NRSF, ameliorates social interaction deficits in a prenatal valproic acid-induced autism mouse model H Kawase, Y Ago, M Naito, M Higuchi, Y Hara, S Hasebe, S Tsukada, ... Pharmacology Biochemistry and Behavior 176, 1-5, 2019 | 13 | 2019 |
| Transcutaneous immunization with a highly active form of XCL1 as a vaccine adjuvant using a hydrophilic gel patch elicits long-term CD8+ T cell responses M Kamei, K Matsuo, H Imanishi, Y Hara, YS Quen, F Kamiyama, N Oiso, ... Journal of Pharmacological Sciences 143 (3), 182-187, 2020 | 7 | 2020 |
